Arthritis

Stimulation of Sensory Neurons Increases Antibody Responses

Retrieved on: 
torsdag, maj 30, 2024

New findings from The Feinstein Institutes for Medical Research bioelectronic medicine scientists show that neurons that help sense pain and prevent illness, called sensory neurons, play an important role in regulating the production of antibodies.

Key Points: 
  • New findings from The Feinstein Institutes for Medical Research bioelectronic medicine scientists show that neurons that help sense pain and prevent illness, called sensory neurons, play an important role in regulating the production of antibodies.
  • (Credit: Feinstein Institutes)
    The study published today in the journal Bioelectronic Medicine — an open-access journal and part of BMC Springer Nature — reveals how activating specific nerves using light stimulation, known as optogenetic activation, results in increased antibody responses, and suggests the potential for neuromodulation to improve antibody responses to fight diseases.
  • When activated with light during immunization, the mice develop specific antibody responses.
  • However, in the absence of these sensory neurons, these mice fail to mount an efficient antibody response.

Prefilled Syringes Global Market Analysis 2024-2029 Featuring Leading Players - Becton Dickinson and Co, Baxter, Gerresheimer, Schott Pharma, West Pharmaceuticals - ResearchAndMarkets.com

Retrieved on: 
onsdag, maj 29, 2024

The current report provides detailed information on the market for prefilled syringes.

Key Points: 
  • The current report provides detailed information on the market for prefilled syringes.
  • This report analyzes the market trends of prefilled syringes with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period 2024 to 2029) and regional markets for prefilled syringes.
  • This report will highlight prefilled syringes' current and future market potential and a detailed competitive environment analysis.
  • The market is segmented based on design into single-chamber prefilled syringes, dual-chamber and customized prefilled syringes.

Eisai: Metoject Subcutaneous Injection Pen (Methotrexate) Pen-Type Autoinjector Launched In Japan

Retrieved on: 
onsdag, maj 22, 2024

TOKYO, May 22, 2024 - (JCN Newswire) - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac group announced today that they have launched the anti-rheumatic agent "Metoject Subcutaneous Injection 7.5mg Pen 0.15mL, 10mg Pen 0.20mL, 12.5mg Pen 0.25mL and 15mg Pen 0.30mL" (methotrexate, "MTX"), in Japan.

Key Points: 
  • TOKYO, May 22, 2024 - (JCN Newswire) - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac group announced today that they have launched the anti-rheumatic agent "Metoject Subcutaneous Injection 7.5mg Pen 0.15mL, 10mg Pen 0.20mL, 12.5mg Pen 0.25mL and 15mg Pen 0.30mL" (methotrexate, "MTX"), in Japan.
  • Metoject Subcutaneous Injection Pen will be the first self-administrable MTX subcutaneous injection pen-type autoinjector for rheumatoid arthritis in Japan and was developed to reduce the burden on patients and improve safety during self- injection.
  • "By adding Metoject Subcutaneous Injection Pen to Eisai's product lineup, we are making further contributions to address the diversified needs of, and increase the benefits provided to, rheumatoid arthritis patients."
  • Product name: Metoject Subcutaneous Injection 7.5mg pen 0.15mL, 10mg pen 0.20mL, 12.5mg pen 0.25mL and 15mg pen 0.30mL
    Generic name: Methotrexate Indication for use: Rheumatoid arthritis Dosage and administration:
    The usual adult dose of methotrexate is 7.5mg injected subcutaneously once a week.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS

Retrieved on: 
tisdag, maj 28, 2024

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS).

Key Points: 
  • NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS).
  • The investigation concerns whether Zoetis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS

Retrieved on: 
tisdag, maj 21, 2024

NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS).

Key Points: 
  • NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS).
  • The investigation concerns whether Zoetis and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Global Healthcare CRM Market Analysis 2024-2032: Rising Need for Cost-Effective Healthcare Solutions, Focus on Lowering Manual Administrative Tasks - ResearchAndMarkets.com

Retrieved on: 
fredag, maj 24, 2024

Market Growth and Size: The market is witnessing strong growth on account of the increasing need for cost-effective healthcare solutions, along with the rising focus on lowering manual administrative tasks.

Key Points: 
  • Market Growth and Size: The market is witnessing strong growth on account of the increasing need for cost-effective healthcare solutions, along with the rising focus on lowering manual administrative tasks.
  • Future Outlook: The future of the healthcare CRM market looks promising, with the rising need for personalized treatment solutions among individuals.
  • What is the breakup of the global healthcare CRM market based on the product?
  • What is the breakup of the global healthcare CRM market based on the end use?

Feinstein Institutes Use Brainstem Vagus Nerve Stimulation to Reduce Inflammation With or Without a Decrease in Heart Rate

Retrieved on: 
onsdag, maj 15, 2024

A new study published in Brain, Behavior and Immunity by The Feinstein Institutes for Medical Research researchers shows that stimulation of the brainstem region where the vagus nerve originates, could help reduce inflammation and heart rate, and improve survival.

Key Points: 
  • A new study published in Brain, Behavior and Immunity by The Feinstein Institutes for Medical Research researchers shows that stimulation of the brainstem region where the vagus nerve originates, could help reduce inflammation and heart rate, and improve survival.
  • This preclinical research opens new therapeutic avenues to address inflammation, and in turn, find ways to suppress heart rate by using vagus nerve stimulation in the brainstem.
  • The results show that this stimulation could lower heart rate and reduce inflammation significantly.
  • They also found that even a regimen of stimulation, which does not affect the heart rate, also suppresses inflammation and improves survival.

The Inner Circle Acknowledges, Jonathan T. Fung, DPM, AACFAS as a Pinnacle Lifetime Member

Retrieved on: 
måndag, maj 13, 2024

BLOOMFIELD, N.J., May 13, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Jonathan T. Fung, DPM, AACFAS is acknowledged as a Pinnacle Lifetime Member for his contributions as a Podiatrist.

Key Points: 
  • BLOOMFIELD, N.J., May 13, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Jonathan T. Fung, DPM, AACFAS is acknowledged as a Pinnacle Lifetime Member for his contributions as a Podiatrist.
  • Dr. Fung, a distinguished podiatrist at Curalta Foot & Ankle, is revolutionizing foot and ankle care in the local community through his commitment to excellence and patient-centered approach.
  • He prioritizes patient education and communication, ensuring that each patient is well-informed and actively involved in their treatment plan.
  • He specializes in adult orthotics, arthritis, bunion and hammertoe correction, foot and ankle surgery, pediatrics surgery, sports medicine, trauma, and reconstructive surgery.

Remission Medical Launches a Navigator Service

Retrieved on: 
fredag, maj 10, 2024

RICHMOND, Va., May 10, 2024 /PRNewswire/ -- Remission Medical, the largest national virtual clinic offering diagnosis and longitudinal care in Rheumatology, powered by video visits and a technology platform focused on escalation avoidance, is now in its third year.

Key Points: 
  • "A big learning we've had since our founding in 2022 is that not every patient issue rises to the level of a video visit," said Kyle Harner, MD, Chief Medical Officer of Remission Medical.
  • "We knew wait times to see a Rheumatologist for diagnosis and longitudinal care were very long in America," said Blake Wehman, Founder & CEO of Remission Medical.
  • But a significant portion of a patient's journey to low disease activity or remission should occur outside the four walls of a medical office, where texting can be effective and efficient," said Blake Wehman, CEO of Remission Medical and proud Remission Medical patient himself.
  • Remission Medical partners with hospital systems nationwide to speed Time to Diagnosis (TTD) and Time to Treatment Initiation (TTI) in Rheumatic Disease, and is based in Richmond, Virginia.